https://omg10.com/4/10736335
Tortugas Neurosciences’ two core programs are licensed oral small molecules in development for schizophrenia and tinnitus. The startup is led by veterans of Sage Therapeutics, a neuroscience biotech acquired last year.
The post Neuro Startup Tortugas Presents $106 Million, Line of Brain Drugs appeared first on MedCity News.
